KINGDON CAPITAL MANAGEMENT, L.L.C. – Cara Therapeutics, Inc. Transaction History
KINGDON CAPITAL MANAGEMENT, L.L.C. portfolio value:
$0
portfolio value
Cara Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | call | Decrease | -100.00% | -150K shares | -1.37M | $9.36 | 0 |
Q3 2022 | share | Increase | +12.68% | 150K shares | 1.67M | $9.36 | 1.33M |
Q2 2022 | share | 0.00% | 0 shares | -3.57M | $9.13 | 1.18M | |
Q2 2022 | call | Increase | 0.00% | 150K shares | 1.37M | $9.13 | 150K |
Q1 2022 | share | Increase | +33.98% | 300K shares | 3.61M | $12.15 | 1.18M |
Q4 2021 | share | Increase | +23.38% | 167.31K shares | -302K | $12.34 | 883K |
Q3 2021 | share | Increase | +65.60% | 283.50K shares | 4.89M | $15.45 | 715.68K |
Q2 2021 | share | Decrease | -40.52% | -294.40K shares | -9.60M | $14.27 | 432.17K |
Q1 2021 | share | Increase | +15.96% | 100K shares | 6.29M | $21.71 | 726.58K |
Q4 2020 | share | 0.00% | 0 shares | 1.50M | $15.13 | 626.58K | |
Q3 2020 | share | 0.00% | 0 shares | -2.74M | $12.73 | 626.58K | |
Q2 2020 | call | Decrease | -100.00% | -144.7K shares | -1.91M | $17.1 | 0 |
Q2 2020 | share | Increase | +30.03% | 144.7K shares | 4.34M | $17.1 | 626.58K |
Q1 2020 | share | Increase | +2.19% | 10.30K shares | -1.23M | $13.21 | 481.88K |
Q1 2020 | call | Increase | 0.00% | 144.7K shares | 1.91M | $13.21 | 144.7K |
Q4 2019 | share | Increase | +67.34% | 189.76K shares | 2.44M | $16.11 | 471.57K |
Q3 2019 | share | Increase | +40.55% | 81.30K shares | 840K | $18.28 | 281.80K |
Q2 2019 | share | Increase | 0.00% | 200.5K shares | 4.31M | $21.5 | 200.5K |
Q3 2017 | call | Decrease | -100.00% | -16.5K shares | -254K | $13.69 | 0 |
Q2 2017 | call | Increase | 0.00% | 16.5K shares | 254K | $15.39 | 16.5K |